Echo Street Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Echo Street Capital Management’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,546	Closed	-$226K	–	545
2023 Q2	$226K	Buy	+5,546	New	+$225K	﹤0.01%	426
2023 Q1	–	Sell	-22,392	Closed	-$781K	–	569
2022 Q4	$781K	Buy	22,392 +15,749	+237%	+$749K	0.01%	196
2022 Q3	$372K	Buy	+6,643	New	+$412K	﹤0.01%	351
2022 Q2	–	Sell	-12,117	Closed	-$881K	–	659
2022 Q1	$881K	Buy	+12,117	New	+$1.03M	0.01%	263
2021 Q4	–	Sell	-2,311	Closed	-$310K	–	715
2021 Q3	$310K	Buy	+2,311	New	+$350K	﹤0.01%	518

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Echo Street Capital Management's NTLA Position: Q3 2023 in Review

Echo Street Capital Management sold out of Intellia Therapeutics (NTLA) in Q3 2023, closing a stake of 5,546 shares — an estimated $226K sold.

Echo Street Capital Management first reported a position in NTLA in Q3 2021 and held it in 5 quarters. The position peaked at $881K in Q1 2022. 285 funds tracked by Wall St. Rank hold NTLA as of Q3 2023.

Echo Street Capital Management reported no remaining Intellia Therapeutics position as of Q3 2023 after selling out during the quarter.
Echo Street Capital Management sold 5,546 Intellia Therapeutics shares in Q3 2023, an estimated $226K.
Echo Street Capital Management first reported a position in Intellia Therapeutics in Q3 2021 and held it in 5 quarters.
Echo Street Capital Management's Intellia Therapeutics position peaked at $881K in Q1 2022.
285 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2023.

Based on Echo Street Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.